GXP Consulting brings more than 100 years of combined GxP leadership across inspections, remediation, quality systems transformation, and regulated execution. The artwork on this page states a record of never having failed a regulatory inspection, more than 15 years of experience per consultant, work across six continents, and engagement with global health authorities including FDA, EMA, MHRA, PMDA, TGA, ANVISA, and Health Canada.
Representative executive engagement types shown here include FDA for-cause inspection leadership, pre-approval inspection leadership, and consent decree and regulatory remediation — with emphasis on inspection readiness, cross-functional alignment, quality-system remediation, and documentation readiness.